Evaluation on the Safety and Efficacy of High-dose Tirofiban in the primary percutaneous Coronary Intervention on patients With Acute ST-elevation Myocardial Infarction
Jun WANG,De-zhao WANG
DOI: https://doi.org/10.3969/j.issn.1007-9572.2015.27.005
2015-01-01
Chinese General Practice
Abstract:Objective To investigate the efficacy and safety of high - dose tirofiban in primary percutaneous coronary intervention(PPCI)on patients with acute ST-elevation myocardial infarction(STEMI). Methods 134 acute STEMI patients who underwent PPCI in Beijing Tiantan Hospital from January 2010 to February 2011 were enrolled in the study. Using random number table method,subjects were divided into standard -dosage group( intravenous injection of 10μg/kg tirofiban within 3 mins followed by continuous intravenous infusion of 0. 150 μg·kg-1 ·min-1 ,SD group)and HD group( intravenous injection of 20μg/kg tirofiban followed by continuous intravenous infusion of 0. 225 μg · kg-1 · min-1 , HD group ), with 67 subjects in each group. The evaluation indicators included thrombolysis in myocardial infarction( TIMI)grade,echocardiography result,and ST-segment recovery rate( STR)at 90 minutes after operation. Safety endpoints during hospitalization and within 90 days after discharge included massive haemorrhage, hemorrhagic stroke and thrombocytopenia;effective endpoints, namely major adverse cardiac events(MACE),included death,re-infarction and acute target lesion revascularization. Results The two groups were not significantly different in basic data(P>0. 05). The two groups were not significantly different in the number of lesion coronary artery, IRA, stent diameter, stent length, the number of stent, unsuccessful PPCI, preoperative TIMI bleeding grading,unfractionated heparin(UFH),low molecular heparin,ACEI/ARB,β receptor inhibitor and statins(P>0. 05);HD group was higher than SD group in the rate of TIMI grade 3(χ2 =7. 309,P=0. 007). The two groups were not significantly different in IVST,LVPWT,LVEDD and LVESD on 90 days after operation(P>0. 05),and HD group was higher than SD group in LVEF on 90 days after operation(P<0. 05). The LVPWT,LVEDD,LVESD and LVEF of Stand-dose group and HD group on 90 days after operation were higher(P<0. 05)than those on the day of admission. HD group was higher than SD group in STR at 90 minutes after operation(t= -3. 678,P<0. 05). HD group was higher than SD group in ST-segment complete recovery rateand was lower than SD groupin ST - segment partial recovery rate(χ2 =9. 046,6. 351;P =0. 003, 0. 012);the two groups were not significantly different in the rate of noST - segment recovery(χ2 =1. 729,P =0. 189). During hospital stay and within 90 days after discharge,the two groups were not significantly different in the total number of bleeding events and the incidence rates of massive hemorrhea,hemorrhagic stroke and thrombocytopenia(P>0. 05). The two groups were not significantly different in the incidence rate of total bleeding events(χ2 =0. 899,P=0. 344). The two groups were not significantly different in the incidence rates of MACE,death,re-infarction and acute target lesion revascularization (P>0. 05);HD group was lower(P<0. 05)than SD group in the incidence rates of MACE and death within 90 days after discharge;HD group was not significantly different in the incidence rates of re - infarction and acute target lesion revascularization within 90 days after discharge( P >0. 05 ) . HD group was lower than SD group in the incidence rate of accumulated MACE(χ2 =4. 808,P=0. 028). The Cox multivariate regression analysis showed that HD tirofiban and CK are influencing factors for MACE(P<0. 05). Conclusion The application of HD tirofiban in PPCI on acute STEMI patients causes lower MACE incidence within 90 days after operation than SD tirofiban,and it causes no increase in the risk of bleeding events.